Alembic share price
You have to be logged in to add this to Watchlist.- ₹94.96(-0.63%)February 16, 2026 11:54:56 AM IST
- NSE
- BSE
- Vol : 67.19 K (NSE + BSE)Last 20 day avg : 213.84 K
Alembic is trading -0.63% lower at Rs 94.96 as compared to its last closing price. Alembic has been trading in the price range of 95.90 & 94.05. Alembic has given -5.65% in this year & -1.70% in the last 5 days. Alembic has TTM P/E ratio 7.91 as compared to the sector P/E of 29.06.The company posted a net profit of 60.13 Crores in its last quarter.Listed peers of Alembic include Torrent Pharmaceuticals (5.12%), Cipla (1.16%), Divi's Laboratories (0.43%).The Mutual Fund holding in Alembic was at 3.36% in 30 Sep 2023. The MF holding has decreased from the last quarter. The FII holding in Alembic was at 1.29% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 16, 2026, 06:28 AM UTC
- BetaHigh volatility1.28Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry2.43Annual dividends as a percentage of the stock price.
- P/BIn line with historical values1.08The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values7.81Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation0.66The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Bullish | 4,282.75 | 5.12 | 1,44,941.89 | 67.32 | 17.1 | 0.83 | 17.62 |
| Cipla | Neutral | 1,346.25 | 1.16 | 1,08,678.06 | 22.95 | 3.87 | 0.87 | 0.81 |
| Divi's Laboratories | Neutral | 6,195.55 | 0.43 | 1,64,171.67 | 78.61 | 11.52 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Bullish | 1,265.40 | -0.17 | 1,05,575.87 | 18.63 | 3.14 | 0.63 | 2.34 |
| Sun Pharmaceutical Industries | Neutral | 1,697.60 | -0.03 | 4,07,325.49 | 36.24 | 5.77 | 0.92 | 0.50 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-12 | Quarterly Results |
| 2025-11-10 | Quarterly Results |
| 2025-08-12 | Quarterly Results & Other |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-02-07 | Quarterly Results & Other |
- IndustryBiotechnology & Drugs
- ISININE426A01027
- BSE Code506235
- NSE CodeALEMBICLTD
Alembic is trading at 94.96 as on Mon Feb 16 2026 06:24:56. This is -0.63% lower as compared to its previous closing price of 95.56.
The market capitalization of Alembic is 2439.17 Cr as on Mon Feb 16 2026 06:24:56.
The 52 wk high for Alembic is 125.70 whereas the 52 wk low is 85.55
Alembic can be analyzed on the following key metrics -
- TTM P/E: 7.91
- Sector P/E: 29.06
- Dividend Yield: 2.51%
- D/E ratio: 0.00
Alembic reported a net profit of 310.68 Cr in 2025.
The Mutual Fund Shareholding was 3.36% at the end of 30 Sep 2023.